BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35225937)

  • 21. Spinal Muscular Atrophy in the Black South African Population: A Matter of Rearrangement?
    Vorster E; Essop FB; Rodda JL; Krause A
    Front Genet; 2020; 11():54. PubMed ID: 32117462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SMA Diagnosis: Detection of SMN1 Deletion with Real-Time mCOP-PCR System Using Fresh Blood DNA.
    Niba ETE; Ar Rochmah M; Harahap NIF; Awano H; Morioka I; Iijima K; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Nishio H; Shinohara M
    Kobe J Med Sci; 2017 Dec; 63(3):E80-E83. PubMed ID: 29434179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Spinal Muscular Atrophy Using a Duplexed Real-Time PCR Approach With Locked Nucleic Acid-Modified Primers.
    Pan J; Zhang C; Teng Y; Zeng S; Chen S; Liang D; Li Z; Wu L
    Ann Lab Med; 2021 Jan; 41(1):101-107. PubMed ID: 32829585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Massachusetts' Findings from Statewide Newborn Screening for Spinal Muscular Atrophy.
    Hale JE; Darras BT; Swoboda KJ; Estrella E; Chen JYH; Abbott MA; Hay BN; Kumar B; Counihan AM; Gerstel-Thompson J; Sahai I; Eaton RB; Comeau AM
    Int J Neonatal Screen; 2021 May; 7(2):. PubMed ID: 34071063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spinal Muscular Atrophy: Advanced Version of Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E49-E53. PubMed ID: 31956256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of SMN1 gene mutations in 78 patients with spinal muscular atrophy].
    Li J; Zhu Y; Zhan Y; Li Y; Chen M; Wang L; He R; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Oct; 34(5):658-661. PubMed ID: 28981927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
    Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
    [No Abstract]   [Full Text] [Related]  

  • 28. High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR.
    Czibere L; Burggraf S; Fleige T; Glück B; Keitel LM; Landt O; Durner J; Röschinger W; Hohenfellner K; Wirth B; Müller-Felber W; Vill K; Becker M
    Eur J Hum Genet; 2020 Jan; 28(1):23-30. PubMed ID: 31363188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinal Muscular Atrophy: New Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E44-E48. PubMed ID: 31956255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutation analysis of SMN1 gene in patients with spinal muscular atrophy].
    DU J; Qu YJ; Xiong H; Li EZ; Jin YW; Bai JL; Wang H; Song F
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):411-5. PubMed ID: 21924051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deletion analysis of SMN1 and NAIP genes in Southern Chinese children with spinal muscular atrophy.
    Liang YH; Chen XL; Yu ZS; Chen CY; Bi S; Mao LG; Zhou BL; Zhang XN
    J Zhejiang Univ Sci B; 2009 Jan; 10(1):29-34. PubMed ID: 19198020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan.
    Kimizu T; Ida S; Okamoto K; Awano H; Niba ETE; Wijaya YOS; Okazaki S; Shimomura H; Lee T; Tominaga K; Nabatame S; Saito T; Hamazaki T; Sakai N; Saito K; Shintaku H; Nozu K; Takeshima Y; Iijima K; Nishio H; Shinohara M
    Int J Neonatal Screen; 2021 Jul; 7(3):. PubMed ID: 34287247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMA screening system using dried blood spots on filter paper: application of COP-PCR to the SMN1 deletion test.
    Kato N; Sa'Adah N; Ar Rochmah M; Harahap NI; Nurputra DK; Sato H; Sadewa AH; Astuti I; Haryana SM; Saito T; Saito K; Nishimura N; Nishio H; Takeuchi A
    Kobe J Med Sci; 2015 Jan; 60(4):E78-85. PubMed ID: 25791416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nested PCR Amplification Secures DNA Template Quality and Quantity in Real-time mCOP-PCR Screening for SMA.
    Wijaya YOS; Niba ETE; Rochmah MA; Harahap NIF; Awano H; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E54-E58. PubMed ID: 31956257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Supplementary value of denaturing high performance liquid chromatography for routine prenatal diagnosis of spinal muscular atrophy by multiple ligation-dependent probe amplification].
    Tan Y; Wang H; Zhao T; Cheng M; Zhang C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Dec; 36(12):1175-1178. PubMed ID: 31813141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn Screening for Spinal Muscular Atrophy: DNA Preparation from Dried Blood Spot and DNA Polymerase Selection in PCR.
    Takeuchi A; Tode C; Nishino M; Wijaya YOS; Niba ETE; Awano H; Takeshima Y; Saito T; Saito K; Lai PS; Bouike Y; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Nov; 65(3):E95-E99. PubMed ID: 32029694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal Muscular Atrophy Update in Best Practices: Recommendations for Diagnosis Considerations.
    Schroth M; Deans J; Arya K; Castro D; De Vivo DC; Gibbons MA; Ionita C; Kuntz NL; Lakhotia A; Neil Knierbein E; Scoto M; Sejersen T; Servais L; Tian C; Waldrop MA; Vázquez-Costa JF
    Neurol Clin Pract; 2024 Aug; 14(4):e200310. PubMed ID: 38915908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs.
    Romanelli Tavares VL; Monfardini F; Lourenço NCV; da Rocha KM; Weinmann K; Pavanello R; Zatz M
    Int J Neonatal Screen; 2021 Aug; 7(3):. PubMed ID: 34449526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular diagnosis of spinal muscular atrophy by multiplex ligation-dependent probe amplification].
    Zeng J; Ke LF; Deng XJ; Cai MY; Tu XD; Lan FH
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3262-4. PubMed ID: 19159550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.